Literature DB >> 7907912

Vulnerability to stress ulcerogenesis in rats differing in anxiety: a dopaminergic correlate.

G B Glavin1.   

Abstract

Dopamine and its agonists, acting through D1/DA1 receptors, have been shown to be effective protective factors against stress ulcerogenesis. Since anxiety has been related to stress ulcer development, we chose to examine dopaminergic activity in rats screened for the extremes of behaviorally manifest anxiety. High anxious rats develop more stress ulcers and more ethanol ulcers, relative to low anxious animals. High anxious rats require greater amounts of dopaminergic agonists for 50% protection against stress ulcer formation. In conditions of exposure to a stressor, high anxious rats lose amygdalar dopamine at a faster rate than do low anxious rats. These results suggest that anxiety is a significant factor in stress ulcer development and that central dopaminergic function is critically involved in mediating this pathogenetic factor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7907912     DOI: 10.1016/0928-4257(93)90011-h

Source DB:  PubMed          Journal:  J Physiol Paris        ISSN: 0928-4257


  3 in total

1.  Bearing grudges and physical health: relationship to smoking, cardiovascular health and ulcers.

Authors:  Erick Messias; Anil Saini; Philip Sinato; Stephen Welch
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-04-23       Impact factor: 4.328

2.  Antisecretory and antioxidative effects of the antidepressants fluvoxamine and mirtazapine on water immersion stress and pyloric ligation-induced gastric ulcer in rats.

Authors:  Asmaa R Abdel-Hamed; Dina M Abo-Elmatty; Soha S Essawy; Mohamed A Taha; Etimad A Huwait; Leena Alghamdi; Maryam A Al-Ghamdi
Journal:  Int J Health Sci (Qassim)       Date:  2022 May-Jun

3.  Antiulcer activity of fluvoxamine in rats and its effect on oxidant and antioxidant parameters in stomach tissue.

Authors:  Hakan Dursun; Mehmet Bilici; Fatih Albayrak; Cengiz Ozturk; Mustafa B Saglam; Hamit H Alp; Halis Suleyman
Journal:  BMC Gastroenterol       Date:  2009-05-20       Impact factor: 3.067

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.